Association of angiotensin converting enzyme inhibitors and angiotensin II receptor blockers with risk of COVID‐19, inflammation level, severity, and death in patients …

X Liu, C Long, Q Xiong, C Chen, J Ma, Y Su… - Clinical … - Wiley Online Library
An association among the use of angiotensin converting enzyme (ACE) inhibitors and
angiotensin‐receptor blockers (ARBs) with the clinical outcomes of coronavirus disease …
被引用次数：77 相关文章
[PDF] scienceopen.com

[PDF][PDF] Association of angiotensin converting enzyme inhibitors and angiotensin II receptor blockers with risk of COVID-19, inflammation level, severity, and death in …

X Liu, C Long, Q Xiong, C Chen, J Ma, Y Su, K Hong - 2020 - scienceopen.com
An association among the use of angiotensin converting enzyme (ACE) inhibitors and
angiotensin-receptor blockers (ARBs) with the clinical outcomes of coronavirus disease …
[PDF] researchgate.net

[PDF][PDF] Association of angiotensin converting enzyme inhibitors and angiotensin II receptor blockers with risk of COVID-19, inflammation level, severity, and death in …

X Liu, C Long, Q Xiong, C Chen, J Ma, Y Su, K Hong - 2020 - researchgate.net
An association among the use of angiotensin converting enzyme (ACE) inhibitors and
angiotensin-receptor blockers (ARBs) with the clinical outcomes of coronavirus disease …

Association of angiotensin converting enzyme inhibitors and angiotensin II receptor blockers with risk of COVID-19, inflammation level, severity, and death in patients …

X Liu, C Long, Q Xiong, C Chen, J Ma, Y Su… - Clinical … - pubmed.ncbi.nlm.nih.gov
An association among the use of angiotensin converting enzyme (ACE) inhibitors and
angiotensin-receptor blockers (ARBs) with the clinical outcomes of coronavirus disease …

Association of angiotensin converting enzyme inhibitors and angiotensin II receptor blockers with risk of COVID-19, inflammation level, severity, and death in patients …

X Liu, C Long, Q Xiong, C Chen, J Ma, Y Su… - Clinical …, 2020 - europepmc.org
An association among the use of angiotensin converting enzyme (ACE) inhibitors and
angiotensin‐receptor blockers (ARBs) with the clinical outcomes of coronavirus disease …
[HTML] nih.gov

[HTML][HTML] Association of angiotensin converting enzyme inhibitors and angiotensin II receptor blockers with risk of COVID‐19, inflammation level, severity, and death in …

X Liu, C Long, Q Xiong, C Chen, J Ma, Y Su, K Hong - Clinical Cardiology - ncbi.nlm.nih.gov
An association among the use of angiotensin converting enzyme (ACE) inhibitors and
angiotensin‐receptor blockers (ARBs) with the clinical outcomes of coronavirus disease …

Association of angiotensin converting enzyme inhibitors and angiotensin II receptor blockers with risk of COVID‐19, inflammation level, severity, and death in patients …

X Liu, C Long, Q Xiong, C Chen, J Ma, Y Su… - Clinical Cardiology, 2020 - cir.nii.ac.jp
抄録< jats: title> Abstract</jats: title>< jats: p> An association among the use of angiotensin
converting enzyme (ACE) inhibitors and angiotensin‐receptor blockers (ARBs) with the …

Association of angiotensin converting enzyme inhibitors and angiotensin II receptor blockers with risk of COVID-19, inflammation level, severity, and death in patients …

X Liu, C Long, Q Xiong, C Chen, J Ma, Y Su… - Clinical …, 2020 - europepmc.org
An association among the use of angiotensin converting enzyme (ACE) inhibitors and
angiotensin‐receptor blockers (ARBs) with the clinical outcomes of coronavirus disease …